Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
NU E Power Corp. Announces Completion of Unwinding its Acquisition of Blu Dot Systems Inc. (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
BioVie Inc
BIVI
Alternate Symbol(s):
BIVIW
Healthcare
Biotechnology
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to...
moderate Alzheimer’s disease; and in Phase 2 clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:BIVI)
New Post
View:
Posts & Comments
Threaded Posts
(51)
•••
bayoubucks
X
Post by
bayoubucks
on Sep 03, 2025 3:30pm
Warrants
If you believe in this company, and there's good reason to, suggest you look at the warrants instead of the stock. Exercisable at $2.50 for 5YEARS! With the stock at $1.64 it's a
...more
(961)
•••
Tradinghands
X
Post by
Tradinghands
on Oct 24, 2024 1:43pm
Still holding up
BIVI has dug itself out of the recent hole so it just shows that patient is needed for returns
Mink Intersects 7.1 Meters of 0.44% Ni, 0.28% Cu, 0.06% Co in Massive Sulphide at Warren Property
posted Mar 12, 2026 9:00am by
Mink Ventures Corp.
-
|
“In spite of the limited exploration drilling so far, Mink continues to intersect significant mineralization and demonstrate the excellent potential for near surface Ni, Cu, Co bearing magmatic sulphide deposition in multiple targets across the 11.3 km2 property. We are particularly encouraged by the higher grade cobalt values associated with the nickel mineralization to date. We look forward to continuing our evaluation of Warren with another drill campaign, which our team has already fully permitted in anticipation of a summer drill program,” said Natasha Dixon, CEO. ...read more
(961)
•••
Tradinghands
X
Post by
Tradinghands
on Oct 21, 2024 10:02am
75% pop!
This started moving on Friday now huge volume with a 75% spike! Friday was the time to buy
(59)
•••
Nibinator
X
Post by
Nibinator
on Jul 22, 2024 6:55pm
BUY BUY BUY BUY BUY
Acuitas fnb takes 44% OWNERSHIP
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Team spotlight: Q+A: Charlene Duffett, Viridian Metals exploration manager
Eshbal quickly expanding commercial and consumer footprint for gluten-free and health food brands
Freegold Ventures reports results from six additional drill holes at its Golden Summit project
BioVaxys and AI-Guided mRNA Immunotherapy Leader Adiverna Enter Collaboration to Develop Companion Animals Vaccines
Podcasts